Post job

Link Medicine CEO and executives

Executive Summary. Based on our data team's research, John F Dee is the Link Medicine's CEO. Link Medicine has 30 employees, of which 4 are in a leadership position.
Work at Link Medicine?
Share your experience

Rate Link Medicine's leadership communication with employees.

Zippia waving zebra
Name & TitleBio
John F Dee

CEO

John F. Dee joined Link in May, 2009. Previously, John served as President and Chief Executive Officer of Hypnion, Inc. from its founding in 2000 until its sale to Eli Lilly in 2007 for $325 million. Under his leadership, Hypnion raised approximately $70 million in venture capital, built a world-class scientific team and technology platform, advanced 5 drugs into clinical trials, and positioned itself as the leader in sleep disorder research and development. Prior to Hypnion, John spent a significant portion of his professional career with McKinsey & Co., Inc., where he conducted performance-improvement and strategic growth initiatives for several major energy and pharmaceutical companies. John has also served on several Boards of Directors and is currently a director of Verenium, Inc. In non-profit pursuits, John led a group of Bay Area economists and business leaders in an extensive public policy review of the San Francisco Bay Area's economic performance. John holds an M.S. in Engineering from Stanford University and an M.B.A. from Harvard University.

David Guyer

Board Member

Dr Edward Scolnick

Board Member

Mike Ross

Board Member

Do you work at Link Medicine?

Does the leadership team provide a clear direction for Link Medicine?

Link Medicine jobs

Link Medicine board members

Name & TitleBio
John F Dee

CEO

John F. Dee joined Link in May, 2009. Previously, John served as President and Chief Executive Officer of Hypnion, Inc. from its founding in 2000 until its sale to Eli Lilly in 2007 for $325 million. Under his leadership, Hypnion raised approximately $70 million in venture capital, built a world-class scientific team and technology platform, advanced 5 drugs into clinical trials, and positioned itself as the leader in sleep disorder research and development. Prior to Hypnion, John spent a significant portion of his professional career with McKinsey & Co., Inc., where he conducted performance-improvement and strategic growth initiatives for several major energy and pharmaceutical companies. John has also served on several Boards of Directors and is currently a director of Verenium, Inc. In non-profit pursuits, John led a group of Bay Area economists and business leaders in an extensive public policy review of the San Francisco Bay Area's economic performance. John holds an M.S. in Engineering from Stanford University and an M.B.A. from Harvard University.

David Guyer

Board Member

Dr Edward Scolnick

Board Member

Mike Ross

Board Member

Link Medicine executives FAQs

Zippia gives an in-depth look into the details of Link Medicine, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Link Medicine. The employee data is based on information from people who have self-reported their past or current employments at Link Medicine. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Link Medicine. The data presented on this page does not represent the view of Link Medicine and its employees or that of Zippia.

Link Medicine may also be known as or be related to Link Medicine and Link Medicine Corp.